Humana (Humana Inc.) is back in focus after its latest earnings update, which combined higher revenue with slightly weaker net income and a downward revision to its full-year GAAP diluted earnings per share (EPS) outlook. The shift has prompted investors to reassess whether the recent share price strength is justified.

UnitedHealth Group (UNH) revised its annual profit forecast downward on Thursday, citing sustained high demand for healthcare services that is expected to keep medical costs elevated through the rest of the year.

Humana (NYSE:HUM) has reported third-quarter profit and revenue that topped estimates, in a positive development for the health insurance group following recent setbacks, News.Az reports citing Investing.